Jeil Pharmaceutical Co.,Ltd (KRX:271980)
11,850
-540 (-4.36%)
At close: Mar 26, 2025, 3:30 PM KST
KRX:271980 Revenue
In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B KRW, down -3.01%. Jeil Pharmaceutical Co.,Ltd had revenue of 186.57B in the quarter ending December 31, 2024, with 3.84% growth.
Revenue
704.54B
Revenue Growth
-3.01%
P/S Ratio
0.26
Revenue / Employee
704.54M
Employees
1,000
Market Cap
180.10B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |